Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis

Table 2 Comparison of patients with cryptogenic cirrhosis with and without liver tissue examination

Variable	Liver biopsy (n = 56, %)	No liver biopsy (n = 78, %)	P
Sex (female)	37 (66)	46 (59)	0.47
DM	13 (23)	40 (51)	0.001
HBP	7 (13)	17 (22)	0.18
Hyperuricemia	3 (5)	10 (13)	0.03
Dyslipidemia	21 (38)	51 (65)	0.002
Overweight (BMI > 25)	46 (82)	57 (73)	0.29
Obesity (BMI > 30)	4 (7)	18 (23)	0.017
MS	10 (18)	29 (37)	0.02
Child-Pugh A	29 (52)	24 (31)	0.02
Age (yr, mean ± SD)	55.8 ± 14.5	53.7 ± 14	0.42
BMI (mean ± SD)	26.2 ± 4.6	27.3 ± 4.6	0.28
ALT (U/L, mean ± SD)	51.8 ± 38	52.9 ± 70	0.91
AST (U/L, mean ± SD)	66 ± 48	68 ± 69	0.86
Albumin (g/dL, mean ± SD)	3.3 ± 0.7	2.9 ± 0.6	0.01
Alkaline Phosphatase (U/L, mean ± SD)	150 ± 72	154 ± 74	0.7
Child-Pugh score (mean ± SD)	6.9 ± 2.7	7.7 ± 1.8	0.06

DM: Diabetes mellitus; HBP: High blood pressure; BMI: Body mass index (calculated as patient’s body weight divided by the square of the height expressed in kg/m²); MS: Metabolic syndrome.